Log in to your account:
Pfizer (PFE) Receives European Approval for ZIRABEV, Biosimilar to Avastin
February 19, 2019 9:33 AM
Pfizer Inc. (NYSE: PFE) today announced the European Commission (EC) has approved ZIRABEV™ for the treatment of metastatic carcinoma of ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Pfizer Receives European Approval for ZIRABEV™ (bevacizumab), a Biosimilar to Avastin®*
February 19, 2019 9:32 AM